Saliva: potential diagnostic value and transmission of 2019-nCoV

被引:8
|
作者
Ruoshi Xu [1 ]
Bomiao Cui [2 ]
Xiaobo Duan [1 ]
Ping Zhang [2 ]
Xuedong Zhou [2 ]
Quan Yuan [1 ]
机构
[1] State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & West China Hospital of Stomatology, Sichuan University
[2] State Key Laboratory of Oral Diseases & Human Saliva Laboratory & National Clinical Research Center for Oral Diseases & West China Hospital of Stomatology, Sichuan University
基金
中国博士后科学基金;
关键词
D O I
暂无
中图分类号
R563.1 [肺炎];
学科分类号
1002 ; 100201 ;
摘要
2019-n Co V epidemic was firstly reported at late December of 2019 and has caused a global outbreak of COVID-19 now. Saliva, a biofluid largely generated from salivary glands in oral cavity, has been reported 2019-n Co V nucleic acid positive. Besides lungs,salivary glands and tongue are possibly another hosts of 2019-n Co V due to expression of ACE2. Close contact or short-range transmission of infectious saliva droplets is a primary mode for 2019-n Co V to disseminate as claimed by WHO, while long-distance saliva aerosol transmission is highly environment dependent within indoor space with aerosol-generating procedures such as dental practice. So far, no direct evidence has been found that 2019-n Co V is vital in air flow for long time. Therefore, to prevent formation of infectious saliva droplets, to thoroughly disinfect indoor air and to block acquisition of saliva droplets could slow down2019-n Co V dissemination. This review summarizes diagnostic value of saliva for 2019-n Co V, possibly direct invasion into oral tissues, and close contact transmission of 2019-n Co V by saliva droplets, expecting to contribute to 2019-n Co V epidemic control.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 50 条
  • [21] Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
    Rothe, Camilla
    Schunk, Mirjam
    Sothmann, Peter
    Bretzel, Gisela
    Froeschl, Guenter
    Wallrauch, Claudia
    Zimmer, Thorbjoern
    Thiel, Verena
    Janke, Christian
    Guggemos, Wolfgang
    Seilmaier, Michael
    Drosten, Christian
    Vollmar, Patrick
    Zwirglmaier, Katrin
    Zange, Sabine
    Woelfel, Roman
    Hoelscher, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10): : 970 - 971
  • [22] 2019-nCoV transmission through the ocular surface must not be ignored
    Lu, Cheng-wei
    Liu, Xiu-fen
    Jia, Zhi-fang
    LANCET, 2020, 395 (10224): : E39 - E39
  • [23] Epitopes for a 2019-nCoV vaccine
    Lucchese, Guglielmo
    CELLULAR & MOLECULAR IMMUNOLOGY, 2020, 17 (05) : 539 - 540
  • [24] Epitopes for a 2019-nCoV vaccine
    Guglielmo Lucchese
    Cellular & Molecular Immunology, 2020, 17 : 539 - 540
  • [25] Emerging understandings of 2019-nCoV
    不详
    LANCET, 2020, 395 (10221): : 311 - 311
  • [26] 2019-nCoV: Polite with children!
    Caselli, Desiree
    Arico, Maurizio
    PEDIATRIC REPORTS, 2020, 12 (01): : 1 - 2
  • [27] Return of the Coronavirus: 2019-nCoV
    Gralinski, Lisa E.
    Menachery, Vineet D.
    VIRUSES-BASEL, 2020, 12 (02):
  • [28] An update on the 2019-nCoV outbreak
    Din, Mohammad Ammad Ud
    Boppana, Leela Krishna Teja
    AMERICAN JOURNAL OF INFECTION CONTROL, 2020, 48 (06) : 713 - 713
  • [29] Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
    Richardson, Peter
    Griffin, Ivan
    Tucker, Catherine
    Smith, Dan
    Oechsle, Olly
    Phelan, Anne
    Stebbing, Justin
    LANCET, 2020, 395 (10223): : E30 - E31
  • [30] 2019 Novel Coronavirus (2019-nCoV) Pneumonia
    Liu, Peng
    Tan, Xian-zheng
    RADIOLOGY, 2020, 295 (01) : 19 - 19